293b cpd has been researched along with 1-ethyl-2-benzimidazolinone in 1 studies
| Studies (293b cpd) | Trials (293b cpd) | Recent Studies (post-2010) (293b cpd) | Studies (1-ethyl-2-benzimidazolinone) | Trials (1-ethyl-2-benzimidazolinone) | Recent Studies (post-2010) (1-ethyl-2-benzimidazolinone) |
|---|---|---|---|---|---|
| 100 | 0 | 16 | 126 | 0 | 37 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cuthbert, AW; Hickman, ME; MacVinish, LJ; Thorn, P | 1 |
1 other study(ies) available for 293b cpd and 1-ethyl-2-benzimidazolinone
| Article | Year |
|---|---|
Activation of Ca(2+)- and cAMP-sensitive K(+) channels in murine colonic epithelia by 1-ethyl-2-benzimidazolone.
Topics: Animals; Benzimidazoles; Calcium; Calcium Channel Agonists; Charybdotoxin; Chlorides; Chromans; Colon; Cyclic AMP; Cystic Fibrosis; Drug Synergism; Electric Conductivity; Intestinal Mucosa; Mice; Potassium Channel Blockers; Potassium Channels; Sulfonamides | 1999 |